Please sign in to follow a disease.
Appendiceal neoplasm
MONDO:0001236A benign or malignant neoplasm involving the appendix.
Also known as: appendix neoplasm, appendix tumor, appendix tumour, neoplasm of appendix, neoplasm of the appendix, neoplasm of vermiform appendix, tumor of appendix, tumor of the appendix
1518 clinical trials for this condition and its sub-types, 30 tagged with Appendiceal neoplasm itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Appendiceal neoplasm
-
Appendix cancer 19 trials · 52 incl. sub-types
2 sub-types
- Appendix carcinoma 11 trials · 42 incl. sub-types Sub-types →
- Appendix lymphoma 0 trials
-
Epithelial tumor of the appendix 0 trials · 42 incl. sub-types
3 sub-types
- Appendix carcinoma 11 trials · 42 incl. sub-types Sub-types →
- Neuroendocrine tumor of the appendix, well differentiated, low or intermediate grade 0 trials · 2 incl. sub-types Sub-types →
- Appendix adenoma 0 trials Sub-types →
-
Appendix neuroendocrine neoplasm 0 trials · 2 incl. sub-types
1 sub-type
- Neuroendocrine tumor of the appendix, well differentiated, low or intermediate grade 0 trials · 2 incl. sub-types Sub-types →
-
Benign neoplasm of appendix 0 trials
1 sub-type
- Appendix leiomyoma 0 trials
Most studied deeper sub-types
-
New vaccine aims to stop colorectal cancer recurrence in High-Risk patients
Disease control OngoingThis study tests an experimental vaccine (RO7198457) in people with stage II or III colorectal cancer who have signs of remaining cancer DNA in their blood after surgery. The goal is to see if the vaccine can prevent the cancer from returning better than simply watching and waiti…
Phase 2 • Sponsor: BioNTech SE • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Chemotherapy sprayed directly into the abdomen: a new attack on stubborn cancers
Disease control OngoingThis phase 1 trial tests a new method of delivering chemotherapy for people with cancers that have spread to the lining of the abdomen (peritoneal carcinomatosis) from gastrointestinal cancers like colorectal, stomach, or pancreatic cancer. The drug, nanoliposomal irinotecan (Oni…
Phase 1 • Sponsor: University Hospital, Ghent • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New pill targets Hard-to-Treat cancers in early trial
Disease control OngoingThis early-phase study tests a new drug called RMC-6291 in adults with advanced cancers (lung, colon, pancreatic) that have a specific KRAS G12C mutation. The goal is to find the safest dose and see how well the drug works. About 222 participants will receive the drug by mouth, a…
Phase 1 • Sponsor: Revolution Medicines, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New hope for hard-to-treat cancers: targeted combo shows promise
Disease control OngoingThis study tests a new drug (JAB-21822) combined with cetuximab in people with advanced colorectal, small intestine, or appendiceal cancers that have a specific KRAS G12C mutation. Participants must have already tried at least one standard treatment. The goal is to see if the com…
Phase 1/2 • Sponsor: Allist Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Heated chemotherapy showdown: which works better for abdominal cancer spread?
Disease control OngoingThis study compares two ways of giving chemotherapy directly into the belly after surgery to remove visible cancer from the lining of the abdomen. The cancer comes from the appendix, colon, or rectum. About 292 adults will be randomly assigned to receive either early post-operati…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Blood test may spot hidden cancer after abdominal surgery
Diagnosis OngoingThis study looks at whether a blood test can detect if cancer comes back after surgery for colorectal or appendix cancer that spread to the abdomen. Researchers will collect blood samples from 55 patients before and after surgery to measure DNA changes. The goal is to see if this…
Sponsor: University of Chicago • Aim: Diagnosis
Last updated Jun 27, 2026 08:01 UTC
-
Doctors question chemo for rare belly cancer: study seeks answers
Knowledge-focused OngoingThis study looks at whether chemotherapy slows tumor growth in people with a rare type of appendiceal cancer that has spread. About 30 participants will be observed with and without chemotherapy to compare tumor growth rates. The goal is to give doctors clearer guidance on whethe…
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC